In the global pharmaceutical industry, the reliable supply of high-quality active pharmaceutical ingredients (APIs) is fundamental to producing effective medicines. Fluorocytosine (CAS 2022-85-7) is one such crucial API, renowned for its potent antifungal properties and its vital role in treating severe fungal infections.

Fluorocytosine is a synthetic fluorinated pyrimidine analog that acts by being converted into fluorouracil within fungal cells. This metabolic process disrupts fungal DNA and protein synthesis, thereby inhibiting fungal growth. Its significance is most pronounced when used in combination therapies, particularly with Amphotericin B, for treating serious infections caused by Candida and Cryptococcus species. It also plays a role in treating chromomycosis.

The product specifications for Fluorocytosine are stringent, reflecting its importance in medicine. It is typically supplied as a white or off-white powder with an assay of ≥98%. Compliance with international pharmacopeial standards such as USP, BP, and EP is essential, ensuring its safety and efficacy. As a leading manufacturer and supplier from China, we are proud to offer Fluorocytosine that meets these exacting requirements.

Sourcing APIs from China offers a strategic advantage, combining high-quality production with competitive pricing. Our commitment as a Fluorocytosine supplier goes beyond mere provision; we ensure that our clients have consistent access to this essential pharmaceutical ingredient through a streamlined online purchasing process. By choosing us, pharmaceutical companies secure a dependable source for Fluorocytosine, supporting their efforts to combat challenging fungal diseases effectively.